Dalvance is used for treating acute bacterial skin and skin structure infections (ABSSSI) which are caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA). DUR001-303 was
The report highlights that a once-daily combination of grazoprevir/elbasvir cured 95% of both the HCV infected, treatment-naive (C-EDGE TN), and HIV/HCV co-infected, treatment-naive (C-EDGE CO-INFXN) patients after 12
The suggestion for granting a marketing authorisation for the drug is based on the positive results obtained from two main studies in patients with advanced malignant melanoma. During
Working in collaboration with scientists at King’s College London and the Mayo Clinic, the scientists described the previously unproven role of the calcium sensing receptor (CaSR) in causing
FSHD is a severe, rare genetic myopathy with an immune component for which there are currently no approved treatments. Being developed as an intravenous protein therapeutic for the
DCR-PH1 is the company’s proprietary DsiRNA-EX-based therapeutic candidate being developed for the treatment of PH1, which often results in kidney failure, and for which there are no approved
Idarucizumab is currently being investigated to specifically reverse the anticoagulant effect of dabigatran, the active ingredient in Pradaxa (dabigatran etexilate mesylate) in patients needing emergency intervention or experiencing
Tong, which is focused on the production, marketing and distribution of health sciences products, has a manufacturing facility located in Tongxiang, China. As part of the deal, Tong
The company is focused on developing and commercializing new medicines for the treatment of vitreo-retinal diseases. RVO is the third indication the company has underway for Jetrea. The
Avycaz is a combination of ceftazidime, a cephalosporin, and avibactam, a non-beta-lactam beta-lactamase inhibitor. The company said that currently only limited clinical safety and efficacy data for Avycaz
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.